LeadArt Biotechnologies
Latest round
- Angel
Last raised
- May 2018
Total raised
- Undisclosed
Investors
- 2
About LeadArt Biotechnologies
Based in Massachusetts, US, and founded in 2022, LeadArt Biotechnologies Inc operates as a biotechnology firm that offers a platform that develops pharmaceutical drugs for cancer patients. The company was founded by Feng Ni (CEO), Yufeng Zhao, and JIe Yan (COO). In December 2022, LeadArt Biotechnologies Inc. The firm offers a biotechnology platform which is Chemoproteomics and automation dual driver. It offers a target ID platform and a drug screening platform. The LeadArt PAL-AfBPP Process offers probe design, target identification, and binding site identification. The drug screening platform uses LeadArt PAL-AfBPP technology which allows drug screening performed in human live cells.
Who invested in LeadArt Biotechnologies
2 investors across 1 round
See all investors in LeadArt Biotechnologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
May 1, 2018
Amount
Undisclosed
Investors
Questions about LeadArt Biotechnologies
Who invested in LeadArt Biotechnologies?
LeadArt Biotechnologies has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has LeadArt Biotechnologies raised?
LeadArt Biotechnologies has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did LeadArt Biotechnologies last raise money?
LeadArt Biotechnologies's most recent round on record is a Angel, in May 2018.
What does LeadArt Biotechnologies do?
Based in Massachusetts, US, and founded in 2022, LeadArt Biotechnologies Inc operates as a biotechnology firm that offers a platform that develops pharmaceutical drugs for cancer patients.
Where is LeadArt Biotechnologies headquartered?
LeadArt Biotechnologies is headquartered in Cambridge, US.
Which VCs invest in companies like LeadArt Biotechnologies?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at LeadArt Biotechnologies's stage. Their profiles are linked below.
VCs backing biotechnology startups at Angel
Raising like LeadArt Biotechnologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.